Systemic Evaluation of Safety and Effectiveness of Levothyroxine Between Different Contract Manufactures at a Medical Center in Northern Taiwan
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: CHEN, Hsin-Yan (Cathay General Hospital, Pharmacy, Taipei, China Taiwan)
- Co-author(s): Kao, C.L. (Cathay General Hospital, Taipei, China Taiwan)
Huang, Y.L. (Cathay General Hospital, Taipei, China Taiwan)
Huang, W.T. (Cathay General Hospital, Taipei, China Taiwan)
The use of levothyroxine for patients is a lifetime issue. Although after substitution, an original pharmaceutical company needs to conduct bioequivalence study before approval, there is no post marketing surveillance. Therefore, health care professionals need evidence to assure that the substitute will produce comparable efficacy and The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.